NSENews Verification3d ago · 18 Sept 2026, 06:41 pm

News Verification

Nestle India Limited · NESTLEIND

✦ AI Summary▲ PositiveRegulatory

Nestle India Limited has clarified that recent news about FSSAI initiating legal action against the company on baby formula is factually incorrect. The company's products are fully compliant with regulations and the labels were approved by FSSAI's expert committee.

Analysis Scores

Earnings Impact2/10
Growth Catalyst1/10
Governance Concern1/10
Regulatory Risk8/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment6/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

The Exchange has sought clarification from Nestle India Limited with respect to recent news item captioned FSSAI initiates legal action against Nestle India on baby formula, shares fall 2%. The response from the Company is attached.

Attachments (1)

📄

NESTLEIND1_18092026184022_BSENSENewsClarification18092026signed.pdf

pdf

Download →
View document text
Nestlé India Limited (CIN : L15202DL1959PLC003786) Nestlé House Jacaranda Marg ‘M’Block, DLF City, Phase – II Gurugram – 122002, Haryana Phone: 0124 – 3940000; E-mail: investor@in.nestle.com; Website: www.nestle.in PKR:SG: 47:2026-27 18th September 2026 BSE Limited (BSE) National Stock Exchange of India Limited (NSE) Phiroze Jeejeebhoy Towers, Exchange Plaza, Plot No. C-1, Dalal Street, Fort, G Block, Bandra Kurla Complex, Mumbai – 400 001 Bandra (East), Mumbai - 400 051 BSE Scrip Code: 500790 NSE Symbol: NESTLEIND Subject: Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“Listing Regulations”): Clarification/ confirmation on the news item appearing in “https://www.moneycontrol.com” Reference: Recent news item which appeared in https://www.moneycontrol.com dated 18th September 2026 quoting “FSSAI initiates legal action against Nestle India on baby formula, shares fall 2%” Dear Madam/ Sir, This is with reference to the query dated 18th September 2026 received from the stock exchanges, regarding clarification/ confirmation sought on the recent news appeared in https://www.moneycontrol.com on 18th September 2026. In this regard, we confirm that the aforesaid news item is factually incorrect, and wish to submit the following clarification issued to media on the aforesaid news item: “Our products are fully compliant with all the applicable regulations. The said products (i.e., NAN EXCELLA PRO & LACTOGEN PRO) and their labels were approved by the expert committee of FSSAI. In response to the notice, we have again submitted our detailed response to the authorities regarding statements appearing on the label, which are factual in nature, and supported by scientific literature. We confirm to adherence of all regulations including all norms and label declarations as per applicable laws. We will continue to work closely and support FSSAI in its efforts towards consumer awareness.” Specific response on the clarification sought by you regarding the aforesaid Publication is provided hereunder: • Whether such negotiations/ events were taking place? If so, you are advised to provide the said information along with the sequence of events in chronological order from the start of negotiations/ events till date: Not Applicable • Whether you/company are aware of any information that has not been announced to the Exchanges which could explain the movement in the trading, if any? Further, you are advised to provide the said information and the reasons for not disclosing the same to the Exchange earlier as required under regulation 30 of the SEBI (LODR) Regulations, 2015: We wish to inform you that all material information that may have a bearing on the Operations/ performance of the Company, which includes all the necessary disclosures in accordance with Regulation 30 of the Listing Regulations have been regularly disclosed to the Stock Exchanges by the Company in a timely and accurate manner, in conformity with the principles governing disclosures and obligations. • The material impact of this article on the Company: None This is for your information and record. Thanking you, Yours truly, NESTLÉ INDIA LIMITED PRAMOD KUMAR RAI COMPANY SECRETARY AND COMPLIANCE OFFICER Regd. Office: 100 / 101, World Trade Centre, Barakhamba Lane, New Delhi – 110 001